High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study
暂无分享,去创建一个
A. Spiro | I. Rosenberg | T. Scott | K. Tucker | Ning Qiao
[1] M. Fava,et al. Nutrition and depression: the role of folate. , 2009, Nutrition reviews.
[2] M. Freedman,et al. Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[3] Samuel Patz,et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[4] R. Mayeux,et al. Dietary factors and Alzheimer's disease , 2004, The Lancet Neurology.
[5] J. Thomas,et al. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. , 2004, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[6] A. Bava,et al. Vitamin B12 and folate depletion in cognition: a review. , 2004, Neurology India.
[7] M. Siebler,et al. Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity , 2004, Journal of the Neurological Sciences.
[8] S. A. Areosa,et al. Folic acid with or without vitamin B12 for cognition and dementia. , 2003, The Cochrane database of systematic reviews.
[9] R. Malouf,et al. Vitamin B6 for cognition , 2003 .
[10] R. Malouf,et al. Vitamin B12 for cognition. , 2003, The Cochrane database of systematic reviews.
[11] C. Dufouil,et al. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people , 2003, Annals of neurology.
[12] T. Shea,et al. Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage , 2002, Journal of neuroscience research.
[13] A Hofman,et al. Homocysteine and cognitive function in the elderly , 2002, Neurology.
[14] Kevin M Bradley,et al. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. , 2002, Age and ageing.
[15] I. Pogribny,et al. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. , 2002, The Journal of nutrition.
[16] C. Maxwell,et al. Serum Folate Levels and Subsequent Adverse Cerebrovascular Outcomes in Elderly Persons , 2002, Dementia and Geriatric Cognitive Disorders.
[17] A. Smith,et al. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. , 2002, Archives of neurology.
[18] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[19] M. Mattson,et al. Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[20] Sudha Seshadri,et al. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .
[21] J. Bryan,et al. B vitamins, cognition, and aging: a review. , 2001, The journals of gerontology. Series B, Psychological sciences and social sciences.
[22] A. McCaddon,et al. Homocysteine and Cognitive Decline in Healthy Elderly , 2001, Dementia and Geriatric Cognitive Disorders.
[23] D. Ashline,et al. Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stress , 2001 .
[24] C. Whitlatch,et al. Are persons with cognitive impairment able to state consistent choices? , 2001, The Gerontologist.
[25] B. Winblad,et al. Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.
[26] H. Arai,et al. Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People , 2001, Stroke.
[27] P. Elwood,et al. Homocysteine and ischaemic stroke in men: the Caerphilly study , 2001, Journal of epidemiology and community health.
[28] Nutrition Board,et al. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline , 2000 .
[29] W. Markesbery,et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. , 2000, The American journal of clinical nutrition.
[30] I. Rosenberg,et al. B vitamins, homocysteine, and neurocognitive function in the elderly. , 2000, The American journal of clinical nutrition.
[31] R. D'Agostino,et al. Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study , 1999, Annals of Internal Medicine.
[32] A. Hofman,et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. , 1999, American journal of epidemiology.
[33] J. Manson,et al. Homocysteine and risk of cardiovascular disease among postmenopausal women. , 1999, JAMA.
[34] M. Hennerici,et al. Homocysteine in cerebral macroangiography and microangiopathy , 1999, The Lancet.
[35] L. Bailey,et al. Folate metabolism and requirements. , 1999, The Journal of nutrition.
[36] A. Hoes,et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. , 1999, Archives of internal medicine.
[37] C. Chung,et al. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. , 1998, Stroke.
[38] S. Kittner,et al. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1998, Stroke.
[39] R Clarke,et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.
[40] A. Folsom,et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. , 1998, Circulation.
[41] D. Hogan,et al. Folate status, vascular disease and cognition in elderly Canadians. , 1998, Age and ageing.
[42] J. Cutler,et al. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[43] L. Parnetti,et al. Role of homocysteine in age-related vascular and non-vascular diseases , 1997, Aging.
[44] Santhosh K. P. Kumar,et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] E. Lesaffre,et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.
[46] A. Spiro,et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.
[47] S. Ebrahim,et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.
[48] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[49] N. Butters,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.
[50] J W Miller,et al. Nutritional factors in physical and cognitive functions of elderly people. , 1992, The American journal of clinical nutrition.
[51] B. Norrving,et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors , 1992, European journal of clinical investigation.
[52] A. McCaddon,et al. Alzheimer's disease: a 'cobalaminergic' hypothesis. , 1992, Medical hypotheses.
[53] M. Beal,et al. Neurochemical characterization of excitotoxin lesions in the cerebral cortex , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] M. Beal,et al. Homocysteic acid lesions in rat striatum spare somatostatin—;Neuropeptide Y (NADPH-diaphorase) neurons , 1990, Neuroscience Letters.
[55] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[56] O. Wolkowitz,et al. RBC folic acid levels and cognitive performance in elderly patients: A preliminary report , 1988, Biological Psychiatry.
[57] W. Endres,et al. A new enzymatic method for pyridoxal-5-phosphate determination , 1981, Journal of Inherited Metabolic Disease.
[58] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[59] T. Stadtman,et al. Vitamin B12 , 1971, Science.
[60] D. Fuchs,et al. Homocysteine and B vitamins in dementia. , 2001, The American journal of clinical nutrition.
[61] C. Gottfries,et al. Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease , 1998, Journal of Neural Transmission.
[62] Y. Sako,et al. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.
[63] D. Wechsler. Manual for the Wechsler Adult Intelligence Scale. , 1955 .